Concurrent pediatric eosinophilic esophagitis and inflammatory bowel disease: a longitudinal single center case��control study and literature review. - National Genomics Data Center (CNCB-NGDC)

Advanced Search

Concurrent pediatric eosinophilic esophagitis and inflammatory bowel disease: a longitudinal single center case��control study and literature review.

Alexandra S Hudson, Michael Pickens, Dale Lee, Kendra L Francis, David L Suskind, Ghassan Wahbeh, Hengqi Betty Zheng

Author Information

Alexandra S Hudson: Division of Pediatric Gastroenterology and Hepatology, Inflammatory Bowel Disease Center, Seattle Children's Hospital, University of Washington, 4800 Sand Point Way NE, OB.9.620.1, Seattle, WA, 98105, USA. ORCID
Michael Pickens: Division of Pediatric Gastroenterology and Hepatology, Inflammatory Bowel Disease Center, Seattle Children's Hospital, University of Washington, 4800 Sand Point Way NE, OB.9.620.1, Seattle, WA, 98105, USA.
Dale Lee: Division of Pediatric Gastroenterology and Hepatology, Inflammatory Bowel Disease Center, Seattle Children's Hospital, University of Washington, 4800 Sand Point Way NE, OB.9.620.1, Seattle, WA, 98105, USA.
Kendra L Francis: Division of Pediatric Gastroenterology and Hepatology, Inflammatory Bowel Disease Center, Seattle Children's Hospital, University of Washington, 4800 Sand Point Way NE, OB.9.620.1, Seattle, WA, 98105, USA.
David L Suskind: Division of Pediatric Gastroenterology and Hepatology, Inflammatory Bowel Disease Center, Seattle Children's Hospital, University of Washington, 4800 Sand Point Way NE, OB.9.620.1, Seattle, WA, 98105, USA.
Ghassan Wahbeh: Division of Pediatric Gastroenterology and Hepatology, Inflammatory Bowel Disease Center, Seattle Children's Hospital, University of Washington, 4800 Sand Point Way NE, OB.9.620.1, Seattle, WA, 98105, USA.
Hengqi Betty Zheng: Division of Pediatric Gastroenterology and Hepatology, Inflammatory Bowel Disease Center, Seattle Children's Hospital, University of Washington, 4800 Sand Point Way NE, OB.9.620.1, Seattle, WA, 98105, USA. Betty.zheng@seattlechildrens.org.

PMID: 39954207 DOI: 10.1007/s12519-025-00882-x

No abstract text available.

Miller FW. The increasing prevalence of autoimmunity and autoimmune diseases: an urgent call to action for improved understanding, diagnosis, treatment, and prevention. Curr Opin Immunol. 2023;80:102266. [DOI: 10.1016/j.coi.2022.102266]
Conrad N, Misra S, Verbakel JY, Verbeke G, Molenberghs G, Taylor PN, et al. Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK. Lancet. 2023;401:1878��90. [DOI: 10.1016/S0140-6736(23)00457-9]
Benchimol EI, Bernstein CN, Bitton A, Carroll MW, Singh H, Otley AR, et al. Trends in epidemiology of pediatric inflammatory bowel disease in Canada: distributed network analysis of multiple population-based provincial health administrative databases. Am J Gastroenterol. 2017;112:1120��34. [DOI: 10.1038/ajg.2017.97]
Lewis JD, Parlett LE, Jonsson Funk ML, Brensinger C, Pate V, Wu Q, et al. Incidence, prevalence, and racial and ethnic distribution of inflammatory bowel disease in the United States. Gastroenterology. 2023;165:1197��205. [DOI: 10.1053/j.gastro.2023.07.003]
Muir A, Falk GW. Eosinophilic esophagitis: a review. JAMA. 2021;326:1310��8. [DOI: 10.1001/jama.2021.14920]
Dellon ES, Hirano I. Epidemiology and natural history of eosinophilic esophagitis. Gastroenterology. 2018;154:319��32.e3. [DOI: 10.1053/j.gastro.2017.06.067]
Furuta GT, Liacouras CA, Collins MH, Gupta SK, Justinich C, Putnam PE, et al. Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology. 2007;133:1342��63. [DOI: 10.1053/j.gastro.2007.08.017]
Uchida AM, Garber JJ, Pyne A, Peterson K, Roelstraete B, Ol��n O, et al. Eosinophilic esophagitis is associated with increased risk of later inflammatory bowel disease in a nationwide Swedish population cohort. United European Gastroenterol J. 2024;12:34��43. [DOI: 10.1002/ueg2.12493]
Fan YC, Steele D, Kochar B, Arsene D, Long MD, Dellon ES. Increased prevalence of esophageal eosinophilia in patients with inflammatory bowel disease. Inflamm Intest Dis. 2019;3:180��6. [DOI: 10.1159/000497236]
Malik A, Liu BD, Zhu L, Kaelber D, Song G. A comprehensive global population-based analysis on the coexistence of eosinophilic esophagitis and inflammatory bowel disease. Dig Dis Sci. 2024;69:892��900. [DOI: 10.1007/s10620-024-08283-2]
Moore H, Wechsler J, Frost C, Whiteside E, Baldassano R, Markowitz J, et al. Comorbid diagnosis of eosinophilic esophagitis and inflammatory bowel disease in the pediatric population. J Pediatr Gastroenterol Nutr. 2021;72:398��403. [DOI: 10.1097/MPG.0000000000003002]
Talathi S, Knight T, Dimmitt R, Mestre J, Jester T. Concurrent eosinophilic esophagitis in pediatric patients with inflammatory bowel disease: a case series. Ann Allergy Asthma Immunol. 2019;123:313��6. [DOI: 10.1016/j.anai.2019.06.010]
Mintz MJ, Ananthakrishnan AN. Phenotype and natural history of inflammatory bowel disease in patients with concomitant eosinophilic esophagitis. Inflamm Bowel Dis. 2021;27:469��75. [DOI: 10.1093/ibd/izaa094]
Splawski J, Aktay AN, Perry S, Baez-Socorro V, DeLozier S, Sferra TJ, et al. Differences in clinical presentation of eosinophilic esophagitis in pediatric patients with ulcerative colitis and crohn disease. J Pediatr Gastroenterol Nutr. 2022;75:76��80. [DOI: 10.1097/MPG.0000000000003460]
Aloi M, D��Arcangelo G, Rossetti D, Bucherini S, Felici E, Romano C, et al. Occurrence and clinical impact of eosinophilic esophagitis in a large cohort of children with inflammatory bowel disease. Inflamm Bowel Dis. 2023;29:1057��64. [DOI: 10.1093/ibd/izac172]
Daperno M, D��Haens G, Van Assche G, Baert F, Bulois P, Maunoury V, et al. Development and validation of a new, simplified endoscopic activity score for Crohn��s disease: the SES-CD. Gastrointest Endosc. 2004;60:505��12. [DOI: 10.1016/S0016-5107(04)01878-4]
Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med. 1987;317:1625��9. [DOI: 10.1056/NEJM198712243172603]
Hirano I, Moy N, Heckman MG, Thomas CS, Gonsalves N, Achem SR. Endoscopic assessment of the oesophageal features of eosinophilic oesophagitis: validation of a novel classification and grading system. Gut. 2013;62:489��95. [DOI: 10.1136/gutjnl-2011-301817]
Turner D, Griffiths AM, Walters TD, Seah T, Markowitz J, Pfefferkorn M, et al. Mathematical weighting of the pediatric Crohn��s disease activity index (PCDAI) and comparison with its other short versions. Inflamm Bowel Dis. 2012;18:55��62. [DOI: 10.1002/ibd.21649]
Turner D, Otley AR, Mack D, Hyams J, de Bruijne J, Uusoue K, et al. Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study. Gastroenterology. 2007;133:423��32. [DOI: 10.1053/j.gastro.2007.05.029]
Migliorisi G, Mastrorocco E, Dal Buono A, Gabbiadini R, Pellegatta G, Spaggiari P, et al. Eosinophils, eosinophilic gastrointestinal diseases, and inflammatory bowel disease: a critical review. J Clin Med. 2024;13:4119. [DOI: 10.3390/jcm13144119]
Bamias G, Cominelli F. Role of type 2 immunity in intestinal inflammation. Curr Opin Gastroenterol. 2015;31:471��6. [DOI: 10.1097/MOG.0000000000000212]

Letter

No available data.